Deals Rumor Mill: Novartis, Statoil, Lanco

Law360, New York (January 9, 2014, 1:02 PM EST) -- Swiss pharmaceutical giant Novartis AG is hammering out the finer points of a deal that would trade its $4.1 billion animal-health business for the over-the-counter products unit of New Jersey-based Merck & Co., bankers told Reuters on Thursday. The asset swap has become the central focus for Novartis, in the midst of an exhaustive review of its portfolio, though it could still opt for an outright sale of the business to a separate buyer. The companies have been in talks “for some time” but have come...
To view the full article, register now.